JPS61103840A - 外皮投与用組成物 - Google Patents

外皮投与用組成物

Info

Publication number
JPS61103840A
JPS61103840A JP59226279A JP22627984A JPS61103840A JP S61103840 A JPS61103840 A JP S61103840A JP 59226279 A JP59226279 A JP 59226279A JP 22627984 A JP22627984 A JP 22627984A JP S61103840 A JPS61103840 A JP S61103840A
Authority
JP
Japan
Prior art keywords
ester
alcohol
alkyl
compound
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP59226279A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0570610B2 (enExample
Inventor
Yoko Abe
容子 阿部
Susumu Sato
進 佐藤
Yoshiaki Ito
嘉章 伊藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nitto Denko Corp
Original Assignee
Nitto Electric Industrial Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nitto Electric Industrial Co Ltd filed Critical Nitto Electric Industrial Co Ltd
Priority to JP59226279A priority Critical patent/JPS61103840A/ja
Priority to US06/784,303 priority patent/US4863952A/en
Priority to DE19853536669 priority patent/DE3536669A1/de
Publication of JPS61103840A publication Critical patent/JPS61103840A/ja
Publication of JPH0570610B2 publication Critical patent/JPH0570610B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
JP59226279A 1984-10-26 1984-10-26 外皮投与用組成物 Granted JPS61103840A (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP59226279A JPS61103840A (ja) 1984-10-26 1984-10-26 外皮投与用組成物
US06/784,303 US4863952A (en) 1984-10-26 1985-10-04 Method of promoting percutaneous drug absorption with 2-pyrrolidin-2-one 5-carboxylic acids and esters thereof
DE19853536669 DE3536669A1 (de) 1984-10-26 1985-10-15 Zusammensetzung fuer die perkutane verabreichung von medikamenten und verfahren zur foerderung der perkutanen absorption von medikamenten

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59226279A JPS61103840A (ja) 1984-10-26 1984-10-26 外皮投与用組成物

Publications (2)

Publication Number Publication Date
JPS61103840A true JPS61103840A (ja) 1986-05-22
JPH0570610B2 JPH0570610B2 (enExample) 1993-10-05

Family

ID=16842717

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59226279A Granted JPS61103840A (ja) 1984-10-26 1984-10-26 外皮投与用組成物

Country Status (3)

Country Link
US (1) US4863952A (enExample)
JP (1) JPS61103840A (enExample)
DE (1) DE3536669A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62187415A (ja) * 1986-02-12 1987-08-15 Lion Corp 経皮吸収促進用組成物

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6160620A (ja) * 1984-09-03 1986-03-28 Teijin Ltd ピログルタミン酸エステル類を含有する医薬品組成物
US4762851A (en) * 1985-11-29 1988-08-09 Merck & Co., Inc. Pyroglutamic acid esters used as dermal penetration enhancers for drugs
JPH0717521B2 (ja) * 1986-03-27 1995-03-01 日東電工株式会社 外皮投与用組成物
DE3617824A1 (de) * 1986-05-27 1987-12-03 Hoechst Ag Zusammensetzung fuer transdermale therapeutische systeme von schleifendiuretika
GR871267B (en) * 1986-08-18 1987-12-24 Chugai Pharmaceutical Co Ltd Method for the manufacture of a pharmaceutical preparation for administration by percutaneous absortion
US5059628A (en) * 1987-09-28 1991-10-22 Nitto Electric Industrial Co., Ltd. Medical composition for percutaneous administration
CA1334646C (en) * 1988-04-08 1995-03-07 James Vanolden Peck Transdermal penetration enhancers
GB8811409D0 (en) * 1988-05-13 1988-06-15 Unilever Plc Cosmetic composition
JPH03232817A (ja) * 1990-02-07 1991-10-16 Showa Yakuhin Kako Kk 貼付剤
JP3686434B2 (ja) * 1993-10-01 2005-08-24 千寿製薬株式会社 コンタクトレンズ用剤の安定化方法
US20040033253A1 (en) * 2002-02-19 2004-02-19 Ihor Shevchuk Acyl opioid antagonists
CN100525767C (zh) 2002-06-10 2009-08-12 欧洲凯尔特公司 防止所含活性剂被误用的经皮给药器的处置系统
US20040126323A1 (en) * 2002-08-20 2004-07-01 Ihor Shevchuk Transdermal dosage form comprising an active agent and a salt and free-base form of an adverse agent
US20080020028A1 (en) * 2003-08-20 2008-01-24 Euro-Celtique S.A. Transdermal dosage form comprising an active agent and a salt and a free-base form of an adverse agent
US20090156565A1 (en) * 2004-12-03 2009-06-18 The Children's Hospital Of Philadelphia Composition and use thereof in enhancing a therapeutic effect of an antiepileptic drug
JP2009530301A (ja) * 2006-03-17 2009-08-27 クローダ，インコーポレイティド アミン／アミド官能化親油性物
FR2908982A1 (fr) * 2006-11-23 2008-05-30 Oreal Composition cosmetique comprenant au moins un solvant volatil hydrocarbone aprotique
EP1974715A1 (de) * 2007-03-31 2008-10-01 Zschimmer & Schwarz GmbH & Co KG Chemische Fabriken Tränklösung für Feuchttücher
EP2335480A1 (en) * 2009-12-15 2011-06-22 Cognis IP Management GmbH Biocide compositions comprising derivatives of pyroglutamic acid

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2102173A1 (en) * 1971-01-18 1972-08-17 Dr. Karl Thomae Gmbh, 7950 Biberach Pyrrolidone carboxylic acid alkyl esters prepn - having therapeutic and cosmetic activity esp for the skin
DE2102172C3 (de) * 1971-01-18 1980-03-20 Dr. Karl Thomae Gmbh, 7950 Biberach Neue Mittel zur Behandlung und Pflege der Haut
LU65921A1 (enExample) * 1972-08-18 1974-02-21
US3975399A (en) * 1974-08-06 1976-08-17 E. I. Du Pont De Nemours And Company 1,5-Disubstituted-2-pyrrolidinones, -3-pyrrolin-2-ones, and -4-pyrrolin-2-ones
DE2456634A1 (de) * 1974-11-29 1976-08-12 Thomae Gmbh Dr K 5-pyrrolidon-(2)-carbonsaeure-phenylalkanolester und deren herstellung,
GB1563199A (en) * 1975-09-10 1980-03-19 Ici Ltd 1,2,4 triazole compounds and their use as pesticides
LU74438A1 (enExample) * 1976-02-26 1977-09-12
US4428883A (en) * 1981-03-06 1984-01-31 The University Of Kentucky Research Foundation Novel method of administering β-blockers and novel dosage forms containing same
JPS59184135A (ja) * 1983-04-04 1984-10-19 Teijin Ltd グリセリンピログルタミン酸エステル類を含有する医薬品組成物
JPS6160620A (ja) * 1984-09-03 1986-03-28 Teijin Ltd ピログルタミン酸エステル類を含有する医薬品組成物

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62187415A (ja) * 1986-02-12 1987-08-15 Lion Corp 経皮吸収促進用組成物

Also Published As

Publication number Publication date
DE3536669A1 (de) 1986-04-30
US4863952A (en) 1989-09-05
JPH0570610B2 (enExample) 1993-10-05

Similar Documents

Publication Publication Date Title
JPS61103840A (ja) 外皮投与用組成物
US4847260A (en) Composition for percutaneous administration
JPS645579B2 (enExample)
JPS611623A (ja) 局所薬および全身薬の皮膚および膜を介する透過促進組成物およびその方法
JPH03236317A (ja) ドパミン誘導体含有経皮用製剤
CA1225594A (en) Method for percutaneously administering physiologically active agents
JPH0383925A (ja) プロスタグランジンｅ１含有の軟膏剤
WO1995028914A1 (en) Percutaneously administrable base composition and percutaneously administrable drug composition prepared therefrom
JPS6133129A (ja) 基剤組成物および外用医薬組成物
JP3608209B2 (ja) クロタミトン配合外用剤
JPS60214744A (ja) 薬物の経皮吸収促進助剤及びこれを含有する外用医薬組成物
JPS60228423A (ja) 基剤組成物および外用医薬組成物
WO1992019271A1 (fr) Composition facilitant l'administration et l'absorption percutanees, et preparation externe pour l'administration percutanee
JPS62226930A (ja) 外皮投与用組成物
JPS61249934A (ja) 外皮投与用組成物
JPS61129139A (ja) 外皮投与用組成物
JPH0713028B2 (ja) 外皮投与用組成物
JPH0570611B2 (enExample)
JP2648960B2 (ja) 外用医薬組成物
JPS5995212A (ja) 基剤組成物及び外用医薬組成物
US5059628A (en) Medical composition for percutaneous administration
JPS61218530A (ja) 外皮投与用組成物
JP4038580B2 (ja) 貼付剤
JPS6013720A (ja) 生理的活性剤の吸収促進剤
JPH01207246A (ja) 外用製剤用基剤組成物及び外用医薬組成物

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term